跳至主要内容
临床试验/CTRI/2018/02/011704
CTRI/2018/02/011704已完成未知

A prospective randomized study to compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.

Institute of liver and Biliary Sciences0 个研究点目标入组 220 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)All patients of chronic liver disease with large esophageal varices.
  • 2)Age more than and equal to 18 years.

排除标准

  • 1)Patients of chronic liver disease with history of upper Gastro Intestinal bleed.
  • 2)Patients of acute on chronic liver failure
  • 3)Thrombosis of splenoportal axis
  • 4)Hepatocellular carcinoma
  • 5)Patients who were on primary variceal ligation sessions as prophylaxis
  • 6)Patients who are beta blocker intolerant (Prior h/o hypotension, bradycardia).
  • 7)Patients who are contraindicated for beta blockers {H/O COPD (Coronary Obstructive Pulmonary Disease), heart block, refractory Ascites, SBP(Spontaneous Bacterial Peritonitis) , HRS(Hepato Renal Syndrome)}.
  • 8)Failure to give consent for inclusion in the study.

研究者

相似试验